MétaCan
Menu
Back to cohort

Healthcare contact days for patients with stage IV non-small cell lung cancer (NSCLC) in Ontario: A population-based study.

2023· article· en· W4388202877 on OpenAlexaffabout
Arjun Gupta, Paul Nguyen, Christopher M. Booth, Timothy P. Hanna

Bibliographic record

VenueJCO Oncology Practice · 2023
Typearticle
Languageen
FieldMedicine
TopicGlobal Cancer Incidence and Screening
Canadian institutionsQueen's UniversityInstitute for Clinical Evaluative Sciences
Fundersnot available
KeywordsMedicineSystemic therapyContext (archaeology)PopulationLung cancerInternal medicineCohortCancerStage (stratigraphy)Retrospective cohort studySurgery

Abstract

fetched live from OpenAlex

484 Background: For people with advanced NSCLC, visits to healthcare facilities can impose time burdens and take over patients’ lives, especially in the context of limited survival. It is unclear if time burdens vary based on use and type of systemic therapy. We sought to describe patterns of contact days— days with any in-person healthcare contact as a measure of potential time toxicity—in a population-based sample. Methods: We created a population-based, retrospective decedent cohort with health administrative data covering the population of Ontario, Canada (15 million), of adults aged ≥20 years diagnosed with stage IV NSCLC in 2014-2017 and died in 2014-2019. We stratified analysis by systemic therapy received (yes vs no), type of systemic therapy: chemotherapy, immunotherapy, or targeted therapy, and lines received (one, two). The primary outcome was contact days measured from diagnosis to death. We calculated percentage contact days as contact days divided by overall survival. We plotted, normalized, and fitted with cubic splines the weekly percentage of contact days to obtain trajectories over the disease course. Results: We identified 5,785 stage IV NSCLC patients (median age, 70 years, 46.3% female, 57.8% adenocarcinoma, 34.3% received systemic therapy). The median (IQR) survival was 108 days (49-426) and median percentage of contact days 33.3%. Median [IQR] overall survival was longer in patients who received systemic therapy vs. not (261 [152-420] days, vs. 66 [34-130] days). The median percentage of contact days was lower in those who received systemic therapy vs. not (22.2% vs. 40.9%). Overall and for subgroups (systemic therapy vs no, type of therapy, receiving one or two lines), normalized trajectories followed a U-shaped distribution, with highest rates immediately following diagnosis, and prior to death, with a lower middle-phase. The difference between the maximal peak and trough was greater in patients who received systemic therapy (peak 34.8% vs trough 15.9%, ‘’deeper U’’) vs. not (39.5% vs 27.6%, ‘’shallower U’’). The trough was slightly lower for targeted therapy (12.3%, vs 15.9% immunotherapy, vs. 17.7% chemotherapy). Conclusions: Patients with stage IV NSCLC spent a significant proportion of days alive with health care contact, with higher contact days immediately post-diagnosis and pre-death (U-shaped curve). Among those not receiving systemic therapy, the high percentage of contact days, short survival, and shallower U-shaped trajectory reflect their poor underlying health and steady need for supportive care. With systemic therapy, those receiving targeted therapy experienced slightly fewer contact days at the trough of their U-shaped trajectory. These data serve as a call to recognize patient time toxicity, improve care delivery efficiency, and better support patients during periods of high burden.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.335
Threshold uncertainty score0.702

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.072
GPT teacher head0.404
Teacher spread0.332 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJCO Oncology PracticeSame topicGlobal Cancer Incidence and ScreeningFrench-language works237,207